People

Carolyne Zimmermann

Carolyne Zimmermann is a life-sciences business-development executive and a former founding member and General Partner of dRx Capital. SonoThera’s original appointment biography credits her with leading dRx initial investments in Omada Health and Cala Health. Her published career includes senior business-development and licensing leadership at Novartis, transactions and innovation partnering at Johnson & Johnson, Chief Business Officer at 4D Molecular Therapeutics and subsequently SonoThera. She earned an engineering-sciences BS at UC San Diego and an MBA at Columbia Business School. The dRx affiliation is historical and not a current fund position.